Haemonetics Corporation is engaged in the development and manufacture of technology to help ensure the blood supply is safe and supplies are adequate. Haemonetics offers its customers surgical blood salvage systems, which are used before, during and after surgery to collect a patient's own blood for reinfusion; automated plasma collection systems that collect plasma, which is then generally processed into therapeutic pharmaceuticals; automated platelet collection systems that enable the collection of a larger volume of platelets from a single donor, which are then generally given to cancer patients and others with bleeding disorders; automated red cell collection systems, developed to maximize the volume of red cells that can be collected from a single donor, thus helping to alleviate blood shortages, and cell processing systems that can be employed to freeze and thaw blood and to wash and remove foreign substances or solutions from blood.